Role of Adenovirus Core Proteins in Innate Signaling and Viral Genome Packaging
腺病毒核心蛋白在先天信号传导和病毒基因组包装中的作用
基本信息
- 批准号:8493994
- 负责人:
- 金额:$ 22.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-07-01 至 2015-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdenovirus InfectionsAdenovirusesAntiviral TherapyBacteriophagesCapsidCell LineCellsCodeComplementComplexCore ProteinDNADNA DamageDNA PackagingDNA biosynthesisDataDevelopmentDouble Stranded DNA VirusElderlyEventFosteringGenesGenomeGoalsGrowthHerpesviridaeImmunocompromised HostIndividualInfectionLung diseasesMilitary PersonnelModelingMolecularMotorPhaseProductionPropertyProtaminesProteinsResearchRoleSignal TransductionSiteStagingTestingToxic effectViralViral Core ProteinsViral GenesViral GenomeViral PackagingViral ProteinsVirionVirusVirus AssemblyVirus DiseasesVirus ReplicationWorkaspergillopepsin IIdesigninnovationinterestmutantpathogenprotein complexrecombinant virusrecombinaseresearch studyresponseviral DNA
项目摘要
DESCRIPTION (provided by applicant): Viruses with linear, dsDNA genomes, such as the adenoviruses (Ad) and herpesviruses, encounter a number of host cell responses that may severely inhibit virus replication. The open ends of the linear viral genomes trigger a cellular DNA damage response (DDR). A DDR severely inhibits Ad DNA replication if unabated. The major Ad core protein, protein VII, protects the viral genome from recognition by the DDR immediately after infection. As protein VII is released from the Ad genome during the early phase of viral infection, Ad inhibits a DDR by alternative mechanisms to allow efficient viral replication. Core protein VII is tightly associated with the viral genome within the Ad virus particle, the capsid. It is not clear how protein VII is packaged into the Ad capsid during virus assembly. A means to conditionally express Ad core protein VII during viral infection has been developed. This approach will be used to study the functions of Ad core protein VII during all aspects of the virus replication cycle. These studies pertain not only to Ad, but to more complex dsDNA viruses such as the herpesviruses. Ads have been recognized in recent years as significant pathogens in immunocompromised patients. Ad infection is also associated with severe respiratory disease in the young, elderly, and in military personnel. There is no virus-specific therapy for Ad infection. Thus, it has become increasingly important to fully understand the Ad replication cycle in order to foster the development of antiviral therapies.
描述(由申请方提供):具有线性双链DNA基因组的病毒,如腺病毒(Ad)和疱疹病毒,会遇到许多可能严重抑制病毒复制的宿主细胞反应。线性病毒基因组的开放末端触发细胞DNA损伤反应(DDR)。DDR如果不减弱,则严重抑制Ad DNA复制。主要的Ad核心蛋白,蛋白VII,保护病毒基因组在感染后立即被DDR识别。由于蛋白VII在病毒感染的早期阶段从Ad基因组释放,Ad通过替代机制抑制DDR以允许有效的病毒复制。核心蛋白VII与Ad病毒颗粒(衣壳)内的病毒基因组紧密相关。尚不清楚蛋白VII在病毒组装期间如何包装到Ad衣壳中。已经开发了在病毒感染期间条件性表达Ad核心蛋白VII的方法。这种方法将用于研究Ad核心蛋白VII在病毒复制周期的各个方面的功能。这些研究不仅涉及Ad,而且涉及更复杂的dsDNA病毒,如疱疹病毒。近年来,广告被认为是免疫功能低下患者的重要病原体。在年轻人、老年人和军人中,Ad感染也与严重的呼吸道疾病有关。没有针对Ad感染的病毒特异性治疗。因此,为了促进抗病毒疗法的发展,充分了解Ad复制周期变得越来越重要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PATRICK HEARING其他文献
PATRICK HEARING的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PATRICK HEARING', 18)}}的其他基金
A Novel Strategy for Recombinant Adeno-Associated Virus Vector Production
重组腺相关病毒载体生产的新策略
- 批准号:
8444147 - 财政年份:2013
- 资助金额:
$ 22.21万 - 项目类别:
A Novel Strategy for Recombinant Adeno-Associated Virus Vector Production
重组腺相关病毒载体生产的新策略
- 批准号:
8601421 - 财政年份:2013
- 资助金额:
$ 22.21万 - 项目类别:
Role of Adenovirus Core Proteins in Innate Signaling and Viral Genome Packaging
腺病毒核心蛋白在先天信号传导和病毒基因组包装中的作用
- 批准号:
8401416 - 财政年份:2012
- 资助金额:
$ 22.21万 - 项目类别:
Regulation of Nuclear Signaling Pathways by the Adenovirus E4-ORF3 Protein
腺病毒 E4-ORF3 蛋白对核信号通路的调节
- 批准号:
10435502 - 财政年份:2007
- 资助金额:
$ 22.21万 - 项目类别:
Regulation of Nuclear Signaling Pathways by the Adenovirus E4-ORF3 Protein
腺病毒 E4-ORF3 蛋白对核信号通路的调节
- 批准号:
8540975 - 财政年份:2007
- 资助金额:
$ 22.21万 - 项目类别:
Regulation of Nuclear Signaling Pathways by the Adenovirus E4 ORF3 Protein
腺病毒 E4 ORF3 蛋白对核信号通路的调节
- 批准号:
7405395 - 财政年份:2007
- 资助金额:
$ 22.21万 - 项目类别:
Regulation of Nuclear Signaling Pathways by the Adenovirus E4 ORF3 Protein
腺病毒 E4 ORF3 蛋白对核信号通路的调节
- 批准号:
7579153 - 财政年份:2007
- 资助金额:
$ 22.21万 - 项目类别:
Regulation of Nuclear Signaling Pathways by the Adenovirus E4-ORF3 Protein
腺病毒 E4-ORF3 蛋白对核信号通路的调节
- 批准号:
8321122 - 财政年份:2007
- 资助金额:
$ 22.21万 - 项目类别:
Regulation of Nuclear Signaling Pathways by the Adenovirus E4-ORF3 Protein
腺病毒 E4-ORF3 蛋白对核信号通路的调节
- 批准号:
9099752 - 财政年份:2007
- 资助金额:
$ 22.21万 - 项目类别:
Regulation of Nuclear Signaling Pathways by the Adenovirus E4-ORF3 Protein
腺病毒 E4-ORF3 蛋白对核信号通路的调节
- 批准号:
8866365 - 财政年份:2007
- 资助金额:
$ 22.21万 - 项目类别:
相似海外基金
RNA interference based therapies for treatment of adenovirus infections in immunosuppressed host
基于 RNA 干扰的疗法用于治疗免疫抑制宿主的腺病毒感染
- 批准号:
211658021 - 财政年份:2012
- 资助金额:
$ 22.21万 - 项目类别:
Research Grants
ASSESSING THE PREVALENCE OF THE BK, CMV, & ADENOVIRUS INFECTIONS IN PED PTS
评估 BK、CMV 的患病率
- 批准号:
7716731 - 财政年份:2008
- 资助金额:
$ 22.21万 - 项目类别:
ASSESSING THE PREVALENCE OF THE BK, CMV, & ADENOVIRUS INFECTIONS IN PED PTS
评估 BK、CMV 的患病率
- 批准号:
7982151 - 财政年份:2008
- 资助金额:
$ 22.21万 - 项目类别:
ASSESSING THE PREVALENCE OF THE BK, CMV, & ADENOVIRUS INFECTIONS IN PED PTS
评估 BK、CMV 的患病率
- 批准号:
7603956 - 财政年份:2006
- 资助金额:
$ 22.21万 - 项目类别:
Immunotherapy of Adenovirus Infections in Stem Cell Transplnt Recipients
干细胞移植受体中腺病毒感染的免疫治疗
- 批准号:
7337161 - 财政年份:2006
- 资助金额:
$ 22.21万 - 项目类别:
Immunotherapy of Adenovirus Infections in Stem Cell Transplant Recipients
干细胞移植受者腺病毒感染的免疫治疗
- 批准号:
7167150 - 财政年份:2006
- 资助金额:
$ 22.21万 - 项目类别:
Immunotherapy of Adenovirus Infections in Stem Cell Transplnt Recipients
干细胞移植受体中腺病毒感染的免疫治疗
- 批准号:
7020895 - 财政年份:2006
- 资助金额:
$ 22.21万 - 项目类别:
Immunotherapy of Adenovirus Infections in Stem Cell Transplnt Recipients
干细胞移植受体中腺病毒感染的免疫治疗
- 批准号:
7545814 - 财政年份:2006
- 资助金额:
$ 22.21万 - 项目类别:
ASSESSING THE PREVALENCE OF THE BK, CMV, & ADENOVIRUS INFECTIONS IN PED PTS
评估 BK、CMV 的患病率
- 批准号:
7368241 - 财政年份:2005
- 资助金额:
$ 22.21万 - 项目类别:
National Surveillance for Emerging Adenovirus Infections
新发腺病毒感染的国家监测
- 批准号:
6899378 - 财政年份:2004
- 资助金额:
$ 22.21万 - 项目类别: